Shop
Panaxea – ICC
This product is available for logged in users only. Please register for an account or login here.
Features & Benefits
ICC an unique combination anti-inflammatory compounds for chronic inflammatory diseases. ICC reduces various inflammatory mediators such as interleukin-6 (IL-6), IL-1 beta, TNF-alpha, prostaglandin E2 and leukotrienes.
Actions
-Reduces various inflammatory mediators
-Including: interleukin-6 (IL-6), IL-1 beta, TNF-alpha, prostaglandin E2 and leukotrienes
Indications
-Chronic Inflammation
-Rheumatoid & osteoarthritis
-Ulcerative colitis
-Crohn’s disease
-Eczema
-SLE
-Cancer Protocols
-Lung cancer
-Breast Cancer
-Colorectal Cancer
-Inflammation induced angiogenesis
Dose & Administration
2 capsules twice daily on empty stomach. For treatment of systemic inflammation alternate with Berberine Complexevery 6 weeks (2 caps 2 times daily on empty stomach).
Ingredients
Gentiana macrophylla
Urtica dioica folium
Ocimum tenuiflorum folium (contains extract 2.5% Ursolic acid) (Lou Le)
Zingiber officinale root (contains extract 20% gingerols) (ShengJjiang)
Boswellia serrata gum (30% AKBA) (Ru Xiang)
Camiella sinensis (Extract EGCG 40%) (Lu Cha)
Citrus reticulata
Perilla frutsecens
Other Ingredients: Vegetable cellulose (hypromellose); Vegetable Stearic Acid; Microcrystalline Cellulose and Vegetable Magnesium Stearate.
Does Not Contain: Wheat, gluten, soy, milk, eggs, fish, crustacean shellfish, tree nuts, peanuts
Caution & Contradindications
Caution:
Rare side-effects of Boswellia include diarrhoea, skin rash, acid reflux and nausea and maybe contraindicated in those with pre-existing gastritis or gastrooesophageal reflux disease (GERD). Studies suggest Boswellia moderates 5-lipoxygenase and therefore may interact with leukotriene inhibitors.
Warning:
Not to be taken by pregnant or lactating women.
Reviews
There are no reviews yet.